Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,181 | 160 | 96.4% |
| Education | $119.00 | 2 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $848.15 | 58 | $0 (2024) |
| Boston Scientific Corporation | $572.80 | 13 | $0 (2023) |
| Gilead Sciences, Inc. | $301.88 | 16 | $0 (2024) |
| Janssen Biotech, Inc. | $209.62 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $181.52 | 10 | $0 (2024) |
| Celgene Corporation | $180.02 | 15 | $0 (2023) |
| RedHill Biopharma Inc. | $144.77 | 3 | $0 (2022) |
| PFIZER INC. | $141.78 | 10 | $0 (2024) |
| Cook Medical LLC | $135.00 | 2 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $124.99 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $448.78 | 23 | ABBVIE INC. ($197.91) |
| 2023 | $406.07 | 14 | Boston Scientific Corporation ($158.99) |
| 2022 | $543.30 | 23 | Celgene Corporation ($152.62) |
| 2021 | $263.34 | 15 | Gilead Sciences, Inc. ($82.78) |
| 2020 | $166.26 | 9 | AbbVie Inc. ($70.54) |
| 2019 | $612.81 | 21 | Boston Scientific Corporation ($258.19) |
| 2018 | $446.67 | 34 | AbbVie, Inc. ($223.79) |
| 2017 | $413.12 | 23 | AbbVie, Inc. ($153.62) |
All Payment Transactions
162 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/23/2024 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: GI COLON PREP | ||||||
| 09/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.57 | General |
| 08/30/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Immunology | ||||||
| 07/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: IMMUNOLOGY | ||||||
| 07/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: IMMUNOLOGY | ||||||
| 07/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Immunology | ||||||
| 06/17/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Education | In-kind items and services | $20.00 | General |
| Category: Rare Disease | ||||||
| 06/12/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Gastroenterology | ||||||
| 04/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: IMMUNOLOGY | ||||||
| 03/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.12 | General |
| 03/12/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 02/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: IMMUNOLOGY | ||||||
| 02/20/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: IMMUNOLOGY | ||||||
| 01/29/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/16/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/08/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/27/2023 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $158.99 | General |
| Category: EXALT Model D_ENDO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 275 | 395 | $251,871 | $36,110 |
| 2022 | 10 | 242 | 307 | $196,405 | $27,894 |
| 2021 | 10 | 253 | 350 | $215,356 | $30,656 |
| 2020 | 11 | 260 | 327 | $187,199 | $32,799 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 61 | $10,431 | $6,081 | 58.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 29 | 30 | $54,390 | $4,779 | 8.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 42 | 42 | $67,830 | $4,095 | 6.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 26 | $8,658 | $3,778 | 43.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 39 | 114 | $14,136 | $3,686 | 26.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 34 | 37 | $43,993 | $2,724 | 6.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 29 | $5,278 | $2,500 | 47.4% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $13,026 | $2,165 | 16.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 11 | $4,950 | $2,111 | 42.7% |
| 45382 | Control of bleeding of upper large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $23,320 | $2,100 | 9.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $5,859 | $2,090 | 35.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 31 | $10,323 | $5,199 | 50.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 34 | 35 | $56,525 | $4,257 | 7.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 36 | $6,156 | $3,118 | 50.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 34 | 36 | $42,804 | $3,003 | 7.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 34 | 82 | $10,168 | $2,625 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 25 | $4,550 | $2,523 | 55.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $5,859 | $2,476 | 42.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 17 | 18 | $32,634 | $2,418 | 7.4% |
| 45382 | Control of bleeding of upper large bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $25,440 | $2,224 | 8.7% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 11 | 11 | $1,946 | $50.26 | 2.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 26 | 26 | $8,658 | $4,428 | 51.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 23 | 23 | $41,699 | $3,991 | 9.6% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 35 | 36 | $58,140 | $3,771 | 6.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 38 | 119 | $14,756 | $3,684 | 25.0% |
About Dr. Daniel Shue, MD
Dr. Daniel Shue, MD is a Gastroenterology healthcare provider based in Torrance, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2010. The National Provider Identifier (NPI) number assigned to this provider is 1487974473.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Shue, MD has received a total of $3,300 in payments from pharmaceutical and medical device companies, with $448.78 received in 2024. These payments were reported across 162 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,181).
As a Medicare-enrolled provider, Shue has provided services to 1,030 Medicare beneficiaries, totaling 1,379 services with total Medicare billing of $127,459. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Torrance, CA
- Active Since 06/02/2010
- Last Updated 09/26/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1487974473
Products in Payments
- ZEPOSIA (Drug) $305.01
- Humira (Biological) $270.09
- DIFICID (Drug) $181.52
- EXALT Model D (Device) $158.99
- RINVOQ (Biological) $145.69
- SKYRIZI (Biological) $142.34
- Creon (Drug) $137.24
- Talicia (Drug) $126.69
- Cook Medical Biliary (Device) $116.76
- STELARA (Biological) $110.62
- REMICADE (Biological) $99.00
- OCALIVA (Drug) $95.72
- INFLECTRA (Biological) $90.25
- GENERAL METAL STENTS GI (Device) $89.60
- GENERAL BILIARY DEVICES (Device) $85.51
- ENTYVIO (Biological) $83.78
- SPYGLASS (Device) $62.50
- RESOLUTION CLIP (Device) $58.64
- XELJANZ (Drug) $51.53
- DUPIXENT (Biological) $48.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Torrance
Dr. Tonny Lee, M.d, M.D
Gastroenterology — Payments: $133,902
Sara Kranke
Gastroenterology — Payments: $75,421
Dr. Jennifer Kolb, Md, MD
Gastroenterology — Payments: $60,794
Dr. Jerome Cohen, M.d, M.D
Gastroenterology — Payments: $38,553
Dr. Edward Piken, M.d, M.D
Gastroenterology — Payments: $23,781
Viktor Eysselein, M.d, M.D
Gastroenterology — Payments: $13,509